Seattle Genetics’ ‘Refreshing’ Enthusiasm Drives Stock Surge; Alkermes Briefly Breaks Out

Seattle Genetics and Alkermes beat fourth-quarter estimates Thursday, pushing Alkermes stock into a brief breakout as SGEN stock soared.

Read More